This compound is a fluorinated derivative of prasugrel, used as an intermediate in the synthesis of pharmaceutical products. Its structure includes a thienopyridine ring system and a cyclopropyl carbonyl group.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1391194-39-0
4-Fluoro prasugrel
pharmaceutical intermediate
Prasugrel
platelet aggregation inhibitor
Prasugrel hydrochloride
active pharmaceutical ingredient
Folic Acid EP Impurity F
Folic acid impurity reference standard
4-(2-Hydroxyethyl)indolin-2-one
Pharmaceutical intermediate for indole derivatives
(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid
Peptide synthesis building block
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Nucleoside phosphoramidite building block
(+/-)-Prasugrel-d3 (acetate-d3)
active pharmaceutical ingredient
[5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
IMTFHRNDRHBYGI-UHFFFAOYSA-N
CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC(=CC=C3)F)C(=O)C4CC4